August 17, 2018 / 1:26 PM / 3 months ago

BUZZ-Evolus Inc: Jumps on Canada's approval of botox rival drug

** Medical aethestics company’s shares up 13 pct to $21.12 premarket - set to recoup its losses over the past five sessions

** Canadian health regulator approved co’s botox drug, DWP-450, for reducing the wrinkles between the eyebrows

** Co says it will market DWP-450 in Canada through partner Clarion Medical Technologies Inc

** Expects to launch drug in the U.S. in spring of 2019 and receive EU approval in the first half of 2019

** Brokerage Mizuho Securities says Canada’s early approval of drug boosts chances of U.S. approval and spring 2019 launch

** Up to Thursday’s close, stock up 63 pct YTD, outperforming a rise of 13 pct on the Nasdaq Composite Index (Reporting by Saumya Sibi Joseph in Bengaluru)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below